Luigi Pacente Selected Research

fluprostenol

4/2020

Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luigi Pacente Research Topics

Disease

2	Keratoconus 01/2020 - 01/2013
2	Astigmatism 01/2020 - 01/2013
1	Acanthamoeba Keratitis 11/2020
1	Corneal Injuries 07/2020
1	Edema (Dropsy) 07/2020
1	Inflammation (Inflammations) 07/2020
1	Hyperemia 04/2020
1	Glaucoma 04/2020
1	Pathologic Dilatation (Ectasia) 01/2013

Drug/Important Bio-Agent (IBA)

3	tocophersolanIBA 11/2020 - 01/2020
3	Riboflavin (Vitamin B2)FDA LinkGeneric 07/2020 - 01/2013
2	SolutionsIBA 11/2020 - 01/2020
1	Succinic Acid (Succinate)IBA 11/2020
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 11/2020
1	ChlorhexidineIBA 11/2020
1	CollagenIBA 07/2020
1	Ophthalmic Solutions (Eye Drops)IBA 07/2020
1	Vitamin E FDA LinkGeneric 07/2020
1	Fibrillar CollagensIBA 07/2020
1	fluprostenolIBA 04/2020
1	Travoprost (Travatan)FDA Link 04/2020

Therapy/Procedure

2	Corneal Cross-Linking 01/2020 - 01/2013
1	Therapeutics 01/2013